Docket Entries by Year
Aug 10, 2018 | 1 | Petition Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Filed by Paul V. Shalhoub of Willkie Farr & Gallagher LLP on behalf of POZEN Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) | |
---|---|---|---|
Aug 10, 2018 | Receipt of Voluntary Petition (Chapter 11)(18-12431) [misc,824] (1717.00) Filing Fee. Receipt number 12714853. Fee amount 1717.00. (Re: Doc # 1) (U.S. Treasury) (Entered: 08/10/2018) | ||
Aug 10, 2018 | 2 | Motion for Joint Administration / Debtors' Motion for Order Authorizing Joint Administration Pursuant to Rule 1015(b) of the Federal Rules of Bankruptcy Procedure filed by Robin Spigel on behalf of POZEN Inc.. (Spigel, Robin) (Entered: 08/10/2018) | |
Aug 10, 2018 | 3 | Motion to Extend Deadline to File Schedules or Provide Required Information / Debtors' Motion for Order Extending Deadline for Debtors to File their Schedules of Assets and Liabilities and Statements of Financial Affairs filed by Robin Spigel on behalf of POZEN Inc.. (Spigel, Robin) (Entered: 08/10/2018) | |
Aug 10, 2018 | 4 | Declaration of Michael Kaseta in Support of Chapter 11 Petitions and First Day Pleadings filed by Robin Spigel on behalf of POZEN Inc.. (Spigel, Robin) (Entered: 08/10/2018) | |
Aug 10, 2018 | Judge Martin Glenn added to the case. (Porter, Minnie). (Entered: 08/10/2018) | ||
Aug 14, 2018 | 5 | Order signed on 8/14/2018 Granting Motion Directing Joint Administration of Related Chapter 11 Cases Under The Lead Case of Aralez Pharmaceuticals US Inc., Case No. 18-12425(MG) (Related Doc # 2). (Gomez, Jessica) (Entered: 08/14/2018) | |
Aug 14, 2018 | An order has been entered in this case directing the procedural consolidation and joint administration of the chapter 11 cases of Aralez Pharmaceuticals US Inc. and its affiliates that have concurrently commenced chapter 11 cases. The docket in the chapter 11 case of Aralez Pharmaceuticals US Inc., Case No. 18-12425 (MG), should be consulted for all matters affecting this case. (Gomez, Jessica). (Entered: 08/14/2018) | ||
Aug 16, 2018 | Claims and Noticing Agent, Prime Clerk LLC Claims Agent, added to the case. (Richards, Beverly). (Entered: 08/16/2018) | ||
Sep 24, 2018 | 6 | Statement of Financial Affairs - Non-Individual Filed by Paul V. Shalhoub on behalf of POZEN Inc.. (Shalhoub, Paul) (Entered: 09/24/2018) | |
There are 5 newer docket entries.To see the entire docket, login, subscribe now, or purchase this single case. |
This case is closed and is no longer being updated.
POZEN Inc.
400 Alexander Park Drive
Princeton, NJ 08540
MERCER-NJ
Tax ID / EIN: xx-xxx7552
fka ARLZ Acquisition II Corp.
Paul V. Shalhoub
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
(212) 728-8764
Fax : (212) 728-8111
Email: maosbny@willkie.com
Robin Spigel
Willkie Far & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
212 728-8822
Fax : 212 728-8111
Email: maosbny@willkie.com
United States Trustee
Office of the United States Trustee
U.S. Federal Office Building
201 Varick Street, Room 1006
New York, NY 10014
(212) 510-0500
Date Filed | Name = parent case | Chapter | Case # |
---|---|---|---|
Feb 8, 2023 | Big Village Group Inc. | 11 | 1:2023bk10176 |
Sep 24, 2021 | Princeton-Windsor Pediatrics, P.A. | 11V | 3:2021bk17501 |
Feb 3, 2021 | Lonestar Pipeline Company, LLC | 11 | 4:2021bk30358 |
Feb 3, 2021 | Frontera Intermediate Holdings LLC | 11 | 4:2021bk30357 |
Feb 3, 2021 | Frontera Holdings LLC | 11 | 4:2021bk30354 |
Feb 3, 2021 | Frontera Generation Limited Partnership | 11 | 4:2021bk30353 |
Feb 3, 2021 | Frontera Generation Holdings LLC | 11 | 4:2021bk30356 |
Feb 3, 2021 | Frontera Generation GP, LLC | 11 | 4:2021bk30355 |
Nov 30, 2020 | Fillit, Inc. | 11 | 3:2020bk23140 |
Jul 1, 2020 | Montage Consulting Inc | 7 | 3:2020bk18163 |
Sep 14, 2018 | Microdermis Corporation | 7 | 4:2018bk35179 |
Aug 10, 2018 | Halton Laboratories LLC | 11 | 1:2018bk12430 |
Aug 10, 2018 | Aralez Pharmaceuticals R&D Inc. | 11 | 1:2018bk12428 |
Aug 10, 2018 | Aralez Pharmaceuticals Management Inc. | 11 | 1:2018bk12427 |
Aug 10, 2018 | Aralez Pharmaceuticals US Inc. | 11 | 1:2018bk12425 |